Table III.
Distribution of several clinicopathological factors according to HS1 expression.
| HS1 expression, n (%) | |||
|---|---|---|---|
| Factor | Low | High | P-value |
| Age, years | 0.334 | ||
| ≤55 | 27 (30.3) | 24 (22.6) | |
| >55 | 54 (60.7) | 75 (70.8) | |
| Unspecifieda | 8 (9.0) | 7 (6.6) | |
| FIGO stage | 0.705 | ||
| I | 38 (42.7) | 43 (40.6) | |
| II | 8 (9.0) | 9 (8.5) | |
| III | 24 (27.0) | 36 (34.0) | |
| IV | 8 (9.0) | 5 (4.7) | |
| Unspecifieda | 11 (12.4) | 13 (12.3) | |
| Histological type | 0.0303 | ||
| Serous | 38 (42.7) | 43 (40.6) | |
| Clear cell | 20 (22.5) | 41 (38.7) | |
| Endometrioid | 21 (23.6) | 18 (17.0) | |
| Mucinous | 10 (11.2) | 4 (3.8) | |
| Chemotherapy | 0.719 | ||
| Taxane plus platinum | 73 (82.0) | 89 (84.0) | |
| Others | 16 (18.0) | 17 (16.0) | |
| Surgery | 0.547 | ||
| Full staging/complete | 34 (38.2) | 45 (42.5) | |
| Non-staging/debulking | 55 (61.8) | 61 (57.5) | |
a
Unspecified as a result of missing data. FIGO, International Federation of Gynecology and Obstetrics; HS1, hematopoietic lineage cell-specific protein 1.